MAYNE PHARMA GROUP LIMITED - Announcements

0.80%

$5.04

Market Cap $409.4M

Healthcare Drug Manufacturers - Specialty & Generic

Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused... Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused on commercializing novel pharmaceuticals. The Company also provides contract development and manufacturing services to clients worldwide. The Company’s segments include Women’s Health, Dermatology, and International. The Women’s Health segment distributes women’s health branded products in the United States. This segment includes NEXTSTELLIS, ANNOVERA, BIJUVA, IMVEXXY and branded pre-natal vitamins. The Dermatology segment distributes established dermatology products in the United States. The International segment is engaged in the manufacture and sale of branded and generic pharmaceutical products globally and the provision of contract development and manufacturing services to third party customers. The Company's products include ACTIKERALL Solution, ASTRIX Capsules and Tablets, MAGNOPLASM Paste and SPLINTEX Splinter Removal Gel, and ANNOVERA Vaginal Ring, among others.More

RCE'S BREAKTHROUGH

Recce Pharmaceuticals (ASX:RCE) accelerates commercialisation with positive Phase II results.

Announcements

Filter Results

All Price Sensitive Only

MYX	Mayne Pharma announces SUBACAP approvable	PRICE SENSITIVE	21/06/12	134.73KB	Share
MYX	Appointment of new sales and marketing director		23/05/12	63.22KB	Share
MYX	US Court decides on Doryx 161 Patent	PRICE SENSITIVE	01/05/12	131.61KB	Share
MYX	Change of Director's Interest Notice		18/04/12	122.51KB	Share
MYX	HY12 Financial Results Presentation		28/02/12	328.28KB	Share
MYX	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/12	1.13MB	Share
MYX	Final Director's Interest Notice		17/02/12	93.86KB	Share
MYX	Initial Director's Interest Notice		13/02/12	90.64KB	Share
MYX	Appendix 3B		13/02/12	329.74KB	Share
MYX	Doryx Generic Update	PRICE SENSITIVE	10/02/12	69.85KB	Share
MYX	Results of Meeting		27/01/12	215.01KB	Share
MYX	Notice of Extraordinary General Meeting/Proxy Form		19/12/11	631.32KB	Share
MYX	SUBACAP Update	PRICE SENSITIVE	15/12/11	81.25KB	Share
MYX	Doryx Generic Update	PRICE SENSITIVE	13/12/11	86.03KB	Share
MYX	MYX APPOINTS SCOTT RICHARDS AS CEO	PRICE SENSITIVE	02/12/11	492.25KB	Share
MYX	Results of Meeting		23/11/11	37.93KB	Share
MYX	Chairman's Address to Shareholders	PRICE SENSITIVE	23/11/11	25.83KB	Share
MYX	2011 AGM Presentation Slides		23/11/11	315.46KB	Share
MYX	Appendix 3B		26/10/11	303.3KB	Share
MYX	Doryx Generic Update	PRICE SENSITIVE	22/09/11	472.19KB	Share
MYX	FDA Approval Of New Dual-Scored 150mg Doryx Tablet	PRICE SENSITIVE	14/09/11	478.46KB	Share
MYX	Notice of Annual General Meeting/Proxy Form		13/09/11	676.51KB	Share
MYX	Annual Report to shareholders		13/09/11	2.09MB	Share
MYX	FY11 Financial Results Presentation		31/08/11	342.14KB	Share
MYX	Preliminary Final Report	PRICE SENSITIVE	31/08/11	393.08KB	Share
MYX	Appendix 3B		28/07/11	293.21KB	Share
MYX	Nomura Biotech Conference Presentation		26/07/11	633.13KB	Share
MYX	Mayne Pharma Market Update	PRICE SENSITIVE	05/07/11	479.25KB	Share
MYX	Mayne Pharma Market Update	PRICE SENSITIVE	15/06/11	79.84KB	Share
MYX	Change of Director's Interest Notice		30/05/11	228.42KB	Share
MYX	Appendix 3B		14/04/11	296.39KB	Share
MYX	Updated Change of Director's Interest Notice		17/03/11	16.13KB	Share
MYX	H10 Financial Results Presentation		25/02/11	251.38KB	Share
MYX	Half Yearly Report and Accounts	PRICE SENSITIVE	25/02/11	632.5KB	Share
MYX	Appendix 3B		18/02/11	266.79KB	Share
MYX	Change of Director's Interest Notice		15/02/11	105.46KB	Share
MYX	Change of Director's Interest Notice		15/02/11	104.25KB	Share
MYX	Appendix 3B		01/02/11	252.42KB	Share
MYX	Change of Director's Interest Notice		01/02/11	31.9KB	Share
MYX	Future Cash Flow Reporting	PRICE SENSITIVE	01/02/11	65.04KB	Share
MYX	Roger Corbett appointed as Chairman		28/01/11	91KB	Share
MYX	Change of Director's Interest Notices		20/01/11	22.23KB	Share
MYX	Appendix 3B		17/01/11	33.33KB	Share
MYX	Security Trading Policy		31/12/10	52.73KB	Share
MYX	Appendix 3B		30/12/10	33.32KB	Share
MYX	Change in Chief Financial Officer / Company Secretary		21/12/10	49.34KB	Share
MYX	Mayna Pharma Files SUBACAP for Registration in the EU	PRICE SENSITIVE	17/12/10	94KB	Share
MYX	Change of Director's Interest Notice		01/12/10	13.71KB	Share
MYX	Initial Director's Interest Notice		19/11/10	21.24KB	Share
MYX	Change of Company name HGN to MYX		19/11/10	28.19KB	Share

MYXMayne Pharma announces SUBACAP approvable
21/06/12	PRICE SENSITIVE	134.73KB	Share
MYXAppointment of new sales and marketing director
23/05/12		63.22KB	Share
MYXUS Court decides on Doryx 161 Patent
01/05/12	PRICE SENSITIVE	131.61KB	Share
MYXChange of Director's Interest Notice
18/04/12		122.51KB	Share
MYXHY12 Financial Results Presentation
28/02/12		328.28KB	Share
MYXHalf Yearly Report and Accounts
28/02/12	PRICE SENSITIVE	1.13MB	Share
MYXFinal Director's Interest Notice
17/02/12		93.86KB	Share
MYXInitial Director's Interest Notice
13/02/12		90.64KB	Share
MYXAppendix 3B
13/02/12		329.74KB	Share
MYXDoryx Generic Update
10/02/12	PRICE SENSITIVE	69.85KB	Share
MYXResults of Meeting
27/01/12		215.01KB	Share
MYXNotice of Extraordinary General Meeting/Proxy Form
19/12/11		631.32KB	Share
MYXSUBACAP Update
15/12/11	PRICE SENSITIVE	81.25KB	Share
MYXDoryx Generic Update
13/12/11	PRICE SENSITIVE	86.03KB	Share
MYXMYX APPOINTS SCOTT RICHARDS AS CEO
02/12/11	PRICE SENSITIVE	492.25KB	Share
MYXResults of Meeting
23/11/11		37.93KB	Share
MYXChairman's Address to Shareholders
23/11/11	PRICE SENSITIVE	25.83KB	Share
MYX2011 AGM Presentation Slides
23/11/11		315.46KB	Share
MYXAppendix 3B
26/10/11		303.3KB	Share
MYXDoryx Generic Update
22/09/11	PRICE SENSITIVE	472.19KB	Share
MYXFDA Approval Of New Dual-Scored 150mg Doryx Tablet
14/09/11	PRICE SENSITIVE	478.46KB	Share
MYXNotice of Annual General Meeting/Proxy Form
13/09/11		676.51KB	Share
MYXAnnual Report to shareholders
13/09/11		2.09MB	Share
MYXFY11 Financial Results Presentation
31/08/11		342.14KB	Share
MYXPreliminary Final Report
31/08/11	PRICE SENSITIVE	393.08KB	Share
MYXAppendix 3B
28/07/11		293.21KB	Share
MYXNomura Biotech Conference Presentation
26/07/11		633.13KB	Share
MYXMayne Pharma Market Update
05/07/11	PRICE SENSITIVE	479.25KB	Share
MYXMayne Pharma Market Update
15/06/11	PRICE SENSITIVE	79.84KB	Share
MYXChange of Director's Interest Notice
30/05/11		228.42KB	Share
MYXAppendix 3B
14/04/11		296.39KB	Share
MYXUpdated Change of Director's Interest Notice
17/03/11		16.13KB	Share
MYXH10 Financial Results Presentation
25/02/11		251.38KB	Share
MYXHalf Yearly Report and Accounts
25/02/11	PRICE SENSITIVE	632.5KB	Share
MYXAppendix 3B
18/02/11		266.79KB	Share
MYXChange of Director's Interest Notice
15/02/11		105.46KB	Share
MYXChange of Director's Interest Notice
15/02/11		104.25KB	Share
MYXAppendix 3B
01/02/11		252.42KB	Share
MYXChange of Director's Interest Notice
01/02/11		31.9KB	Share
MYXFuture Cash Flow Reporting
01/02/11	PRICE SENSITIVE	65.04KB	Share
MYXRoger Corbett appointed as Chairman
28/01/11		91KB	Share
MYXChange of Director's Interest Notices
20/01/11		22.23KB	Share
MYXAppendix 3B
17/01/11		33.33KB	Share
MYXSecurity Trading Policy
31/12/10		52.73KB	Share
MYXAppendix 3B
30/12/10		33.32KB	Share
MYXChange in Chief Financial Officer / Company Secretary
21/12/10		49.34KB	Share
MYXMayna Pharma Files SUBACAP for Registration in the EU
17/12/10	PRICE SENSITIVE	94KB	Share
MYXChange of Director's Interest Notice
01/12/10		13.71KB	Share
MYXInitial Director's Interest Notice
19/11/10		21.24KB	Share
MYXChange of Company name HGN to MYX
19/11/10		28.19KB	Share

REFRESH

First 5 6 7 8 9

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $5.04		Change 0.040(0.80%)		Mkt cap ! $409.4M

Open	High	Low	Value	Volume
$5.02	$5.04	$5.00	$1.420M	283.1K

Buyers (Bids)

No.	Vol.	Price($)
2	2810	$5.02

Sellers (Offers)

Price($)	Vol.	No.
$5.05	5950	2

View Market Depth

No.	Vol.	Price($)
2	41318	5.000
3	12880	4.980
2	15084	4.970
3	7610	4.960
7	17380	4.950

Price($)	Vol.	No.
5.050	5950	2
5.080	2631	2
5.100	25359	3
5.140	2000	1
5.150	25000	1

Last trade - 16.10pm 13/08/2025 (20 minute delay)


Last $5.04		Change 0.040 ( 0.80 %)
Open	High	Low	Volume
$5.01	$5.04	$5.00	12780
Last updated 15.59pm 13/08/2025 ?

MYX (ASX) Chart

MAYNE PHARMA GROUP LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories